For 500x12 µl reactions (20x): QIAGEN Cell and Gene Therapy assay for GFP to be used with the QIAcuity dPCR system
✓ 24/7 automatic processing of online orders
✓ Knowledgeable and professional Product & Technical Support
✓ Fast and reliable (re)-ordering
Features
A broad offering of ten different wet-lab validated dPCR CGT assays
Assays with different fluorophore choices allow multiplexing to sustain more information from one sample
An easy and fast workflow comparable to qPCR
Product Details
Adeno-associated virus (AAV) is a widely used viral vector in gene therapy applications. However, the generation and purification of the viral vectors require rigorous quality control to enable safe and reliable dosing during clinical studies or patient care. The ability to accurately quantify vector titers and detect contamination is critical for safe and effective AAV-based gene therapies.
Performance
The QIAcuity Cell and Gene Therapy dPCR Assays are a broad offering of ten different wet-lab validated dPCR CGT assays that come in multiple fluorophores, enabling superior accuracy, reproducibility and a dynamic range of at least 4 orders of magnitude with speed in measuring viral titers in a multiplex setup. The assays work in conjunction with the QIAcuity Digital PCR System, QIAcuity Probe PCR Kit and QIAcuity Nanoplates, offering an end-to-end dPCR workflow comparable to qPCR, but delivering an absolute quantification of AAV vector genome copies in your sample. The assays have been designed with the requirements of biopharma manufacturing and QC in mind.